Keyphrases
Anthracyclines
100%
P-glycoprotein (P-gp)
100%
Locally Advanced Breast Cancer
100%
Neoadjuvant Chemotherapy
100%
P-glycoprotein Expression
100%
Breast Cancer Patients
60%
Clinical Response
60%
Pathological Response
60%
Confidence Interval
40%
Relative Risk
40%
Immunohistochemical Analysis
20%
Overall Survival
20%
Non-associated
20%
Prospective Cohort Study
20%
Nave
20%
Predictive Factors
20%
Biopsy Specimen
20%
3-cycle
20%
Chemoresistance
20%
Expression Response
20%
Response to Neoadjuvant Chemotherapy
20%
Pathological Complete Response
20%
Luminal B Subtype
20%
Invasive Ductal
20%
Patient Response
20%
Post-neoadjuvant
20%
INIS
cancer
100%
breasts
100%
glycoproteins
100%
chemotherapy
100%
patients
50%
risks
25%
hospitals
25%
luminal
12%
surgery
12%
biopsy
12%
Medicine and Dentistry
Anthracycline
100%
Neoadjuvant Chemotherapy
100%
Locally Advanced Breast Cancer
100%
ABC Transporter Subfamily B
100%
Immunohistochemistry
12%
Overall Survival
12%
Prospective Cohort Study
12%
Predictive Factor
12%
Drug Resistance
12%
Biopsy Sample
12%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
100%
Chemotherapy
100%
Anthracycline
100%
P-Glycoprotein
100%
Overall Survival
12%
Drug Resistance
12%
Prospective Cohort Study
12%
Biochemistry, Genetics and Molecular Biology
P-Glycoprotein
100%
Anthracycline
100%
Overall Survival
12%
Drug Resistance
12%
Prospective Cohort Study
12%
Neuroscience
Anthracycline
100%
ABC Transporter Subfamily B
100%
Immunohistochemistry
12%
Drug Resistance
12%